ArticleWorld journal of urology2023
Active stone removal is a safe option for ocotogenarians and nonagenarians with nephrolithiasis.
Article in World journal of urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 3 syntheses or guidelines pooled it, 9 citations in OpenAlex.
- Pooled it
- Safety and efficacy of percutaneous nephrolithotomy in elderly patients: a systematic review and meta-analysis by the EAU-YAU urolithiasis and EAU endourology sections.World journal of urology · 2026Pooled it
- Ureteroscopy for stone disease in the elderly. is it safe and effective? A systematic review and meta-analysis.World journal of urology · 2025Pooled it
- Supine percutaneous nephrolithotomy in patients aged 80 years and older: a propensity score-matched evaluation of safety and efficacy.World journal of urology · 2025Article
- Mini-Endoscopic Combined Intrarenal Surgery in Patients with Poor Performance Status: A Retrospective Analysis of Postoperative Fever in Over 1000 Cases.Urology research & practice · 2025Article
- Time-sensitive elements in elective treatment of urinary lithiasis: a narrative review.Translational andrology and urology · 2025Review
- Acknowledging acute kidney disease following ureteroscopy and laser lithotripsy: results from a tertiary care referral center.International urology and nephrology · 2024Article
- Utility of the modified 5-item frailty index as a predictor of postoperative febrile urinary tract infection in patients who underwent ureteroscopy with laser lithotripsy.World journal of urology · 2024Article
- Is ureteroscopy and active stone treatment safe and effective in octogenarians? A review of current literature.Arab journal of urology · 2024Review
- Drivers of calcium oxalate stone formation in the octogenarian population.World journal of urology · 2023Article
- Active stone removal for ocotogenarians and nonagenarians with nephrolithiasis: pros or cons.World journal of urology · 2023Article
Corrections and comments
- Commented on by
Authors and funding
12 authors at 6 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the contemporary in-hospital management of octogenarians and nonagenarians with renal calculi. MATERIAL AND
methodsA multicentric retrospective evaluation of patients aged ≥ 80 years hospitalized with kidney stones between 01/2000 and 12/2019. Stone and patient related data were collected, including stone size and location, geriatric status and comorbidities. Surgical treatment patterns and outcome were assessed.
resultsA total of 299 patients (57% female) with kidney stones were analyzed. Mean age was 84.7 years. Patients were largely multimorbid (ASA ≥ 3 in 70%) and about 25% were classified as frail. Active stone treatment was performed in 65% and 35% were treated with urinary diversion (stent or nephrostomy). Prognostic factors for receiving an active stone treatment were age < 90 years, male sex, stone size and quantity, and performance status. Mean overall survival was 23.7 months and when stratified to treatment mean survival were 21 months after urinary diversion, 28 months after URS, 29 months after PCNL and 45 months after SWL.
conclusionAge, frailty and performance-status as well as stone size and quantity are predictors for active stone treatment. Octogenarians and nonagenarians, who are considered fit for surgery, tend to live long enough to profit from active stone treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.